Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco A Perin

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cardiovascular Diagnosis and Therapy|January 23, 2015
Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trialJulio F Marchini, Wilton F Gomes, Bruno Moulin, et al.
Revista Portuguesa De Cardiologia|January 6, 2021
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trialGuy F A Prado, Alexandre A C Abizaid, George C Meireles, et al.
Revista Espanola De Cardiologia (English Ed.)|January 24, 2018
Impact of Acute Kidney Injury on Short- and Long-term Outcomes After Transcatheter Aortic Valve ImplantationAntonio C B Nunes Filho, Marcelo Katz, Carlos M Campos, et al.
American Heart Journal|December 1, 2012
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter studyFausto Feres, Ricardo A Costa, Deepak L Bhatt, et al.
European Heart Journal. Cardiovascular Imaging|March 2, 2016
Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patientsJamil R Cade, Gilberto Szarf, Maria Eduarda M de Siqueira, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
BMC Cardiovascular Disorders|August 18, 2012
Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V TrialWhady Hueb, Bernard J Gersh, Paulo Cury Rezende, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cardiovascular Diagnosis and Therapy|January 23, 2015
Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trialJulio F Marchini, Wilton F Gomes, Bruno Moulin, et al.
Revista Portuguesa De Cardiologia|January 6, 2021
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trialGuy F A Prado, Alexandre A C Abizaid, George C Meireles, et al.
Revista Espanola De Cardiologia (English Ed.)|January 24, 2018
Impact of Acute Kidney Injury on Short- and Long-term Outcomes After Transcatheter Aortic Valve ImplantationAntonio C B Nunes Filho, Marcelo Katz, Carlos M Campos, et al.
American Heart Journal|December 1, 2012
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter studyFausto Feres, Ricardo A Costa, Deepak L Bhatt, et al.
European Heart Journal. Cardiovascular Imaging|March 2, 2016
Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patientsJamil R Cade, Gilberto Szarf, Maria Eduarda M de Siqueira, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
BMC Cardiovascular Disorders|August 18, 2012
Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V TrialWhady Hueb, Bernard J Gersh, Paulo Cury Rezende, et al.
Pageof 3